PG vs TXMD · P/E 25, rev $84.28B vs rev $1.8M
Procter & Gamble Company (PG) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the PG and TXMD stock pages for the full models.
Not investment advice.